Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05555121Phase 2Suspended
Phase 2, open-label trial of progesterone in infertility (2 arms), sponsored by clinique ovo. Primary endpoint: Ongoing pregnancy rate at 8 weeks. Started Dec 2022; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05555121.